|
BRPI0721138A2
(pt)
|
2006-12-22 |
2014-04-01 |
Hoffmann La Roche |
Derivados de espiro-piperidina
|
|
AU2013201306B2
(en)
*
|
2007-03-12 |
2015-11-12 |
Glaxosmithkline Llc |
Phenyl Amino Pyrimidine Compounds and Uses Thereof
|
|
AU2016200866B2
(en)
*
|
2007-03-12 |
2017-06-22 |
Glaxosmithkline Llc |
Phenyl amino pyrimidine compounds and uses thereof
|
|
US8486941B2
(en)
|
2007-03-12 |
2013-07-16 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine compounds and uses thereof
|
|
EP2137165B1
(en)
*
|
2007-04-24 |
2013-04-24 |
Ingenium Pharmaceuticals GmbH |
Inhibitors of protein kinases
|
|
JP5611826B2
(ja)
|
2007-09-04 |
2014-10-22 |
ザ スクリプス リサーチ インスティテュート |
タンパク質キナーゼ阻害剤としての置換されたピリミジニル−アミン
|
|
RU2010132728A
(ru)
|
2008-01-11 |
2012-02-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Модуляторы бета-амилоида
|
|
CA2713716A1
(en)
*
|
2008-02-22 |
2009-08-27 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
MX2011003246A
(es)
|
2008-10-09 |
2011-04-21 |
Hoffmann La Roche |
Moduladores de beta amiloide.
|
|
JP5378532B2
(ja)
|
2008-11-10 |
2013-12-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
複素環γ−セクレターゼモジュレーター
|
|
WO2011046970A1
(en)
*
|
2009-10-12 |
2011-04-21 |
Myrexis, Inc. |
Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
|
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
CN102858767B
(zh)
|
2009-12-17 |
2015-08-19 |
默沙东公司 |
作为syk抑制剂的氨基嘧啶
|
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
|
CN104086528A
(zh)
|
2010-07-15 |
2014-10-08 |
拜耳知识产权有限责任公司 |
作为杀虫剂的新杂环化合物
|
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
CA2806670A1
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
|
|
US9845489B2
(en)
|
2010-07-26 |
2017-12-19 |
Biomatrica, Inc. |
Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
|
CN103270029B
(zh)
*
|
2010-10-22 |
2016-01-20 |
拜耳知识产权有限责任公司 |
作为农药的杂环化合物
|
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
|
KR101961500B1
(ko)
|
2011-02-28 |
2019-03-22 |
어레이 바이오파마 인크. |
세린/트레오닌 키나제 억제제
|
|
JP6147727B2
(ja)
|
2011-04-01 |
2017-06-14 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼｂｔｋ阻害剤としての置換ｎ−（３−（ピリミジン−４−イル）フェニル）アクリルアミド類似体
|
|
US20140288044A1
(en)
*
|
2011-04-12 |
2014-09-25 |
Alzheimer's Institute Of America, Inc. |
Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
|
|
US8916557B2
(en)
|
2011-04-19 |
2014-12-23 |
Bayer Intellectual Property Gmbh |
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
|
|
MX2013013090A
(es)
|
2011-05-10 |
2013-12-16 |
Merck Sharp & Dohme |
Aminopirimidinas como inhibidores de tirosina cinaza del bazo.
|
|
EP2706852B1
(en)
|
2011-05-10 |
2018-08-22 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
|
US9120785B2
(en)
|
2011-05-10 |
2015-09-01 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as Syk inhibitors
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
ES2729947T3
(es)
*
|
2011-07-12 |
2019-11-07 |
Dow Agrosciences Llc |
Composiciones pesticidas y procedimientos relacionados con las mismas
|
|
RU2014108140A
(ru)
|
2011-08-04 |
2015-09-10 |
Эррэй Биофарма Инк. |
Соединение на основе хинозолина в качестве ингибиторов серен-треониновых киназ
|
|
DE102011112978A1
(de)
*
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
CA2848616A1
(en)
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
US9133171B2
(en)
|
2011-09-16 |
2015-09-15 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
UA116774C2
(uk)
|
2012-03-01 |
2018-05-10 |
Еррей Біофарма Інк. |
Інгібітори серин/треонінкінази
|
|
HUE042374T2
(hu)
|
2012-06-13 |
2019-06-28 |
Incyte Holdings Corp |
Szubsztituált triciklusos vegyületek mint FGFR inhibitorok
|
|
US8809359B2
(en)
|
2012-06-29 |
2014-08-19 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine bicyclic compounds and uses thereof
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
KR20150047597A
(ko)
|
2012-08-27 |
2015-05-04 |
어레이 바이오파마 인크. |
과증식성 질환의 치료를 위한 세린/트레오닌 키나아제 억제제
|
|
EP3680238A1
(en)
*
|
2012-10-04 |
2020-07-15 |
University of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
CA2887465A1
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
JP6277195B2
(ja)
|
2012-10-18 |
2018-02-07 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホン基を含んでいる５−フルオロ−ｎ−（ピリジン−２−イル）ピリジン−２−アミン誘導体
|
|
CN105102434A
(zh)
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
WO2014100755A2
(en)
|
2012-12-20 |
2014-06-26 |
Biomatrica, Inc. |
Formulations and methods for stabilizing pcr reagents
|
|
GB201303109D0
(en)
*
|
2013-02-21 |
2013-04-10 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
HUE036571T2
(hu)
|
2013-04-19 |
2018-07-30 |
Incyte Holdings Corp |
Biciklusos heterociklusok mint FGFR inhibitorok
|
|
CN105491883B
(zh)
|
2013-06-13 |
2018-11-02 |
生物马特里卡公司 |
细胞稳定化
|
|
ES2786373T3
(es)
|
2014-06-10 |
2020-10-09 |
Biomatrica Inc |
Estabilización de trombocitos a temperaturas ambiente
|
|
TWI681954B
(zh)
|
2014-06-12 |
2020-01-11 |
美商西爾拉癌症醫學公司 |
Ｎ-（氰基甲基）-４-（２-（４-𠰌啉基苯基胺基）嘧啶-４-基）苯甲醯胺
|
|
JP2017531003A
(ja)
|
2014-10-16 |
2017-10-19 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホン基を含有するフッ化ベンゾフラニル−ピリミジン誘導体
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
MX388991B
(es)
|
2015-02-20 |
2025-03-20 |
Incyte Corp |
Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr)
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
WO2016150893A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
EP3273963A1
(en)
|
2015-03-24 |
2018-01-31 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
RS62639B1
(sr)
|
2015-07-06 |
2021-12-31 |
Alkermes Inc |
Hetero-halo inhibitori histonskih deacetilaza
|
|
ES2786552T3
(es)
|
2015-09-29 |
2020-10-13 |
Bayer Pharma AG |
Compuestos de sulfondiimina macrocíclicos nuevos
|
|
WO2017060167A1
(en)
|
2015-10-08 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Novel modified macrocyclic compounds
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
CN108699048B
(zh)
|
2015-10-12 |
2021-12-28 |
株式会社钟根堂 |
作为组蛋白脱乙酰基酶6抑制剂的噁二唑胺衍生物化合物及包含所述化合物的药物组合物
|
|
SG11201804776SA
(en)
|
2015-12-08 |
2018-07-30 |
Biomatrica Inc |
Reduction of erythrocyte sedimentation rate
|
|
CN110818690B
(zh)
|
2016-07-26 |
2021-08-10 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物
|
|
US20190231751A1
(en)
*
|
2016-09-12 |
2019-08-01 |
Imago Pharmaceuticals, Inc. |
Treatment of fibrotic disorders with jun n-terminal kinase inhibitors
|
|
AU2018207402B2
(en)
|
2017-01-11 |
2023-09-28 |
Alkermes, Inc. |
Bicyclic inhibitors of histone deacetylase
|
|
WO2018152223A1
(en)
*
|
2017-02-15 |
2018-08-23 |
University Of Massachusetts |
Methods of treating angiogenesis-related disorders using jnk3 inhibitors
|
|
GB201702947D0
(en)
|
2017-02-23 |
2017-04-12 |
Domainex Ltd |
Novel compounds
|
|
CA3057891A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
GB201705263D0
(en)
*
|
2017-03-31 |
2017-05-17 |
Probiodrug Ag |
Novel inhibitors
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
EA039417B1
(ru)
|
2017-08-07 |
2022-01-25 |
Родин Терапеутикс, Инк. |
Бициклические ингибиторы гистондеацетилазы
|
|
EP3697772A1
(en)
*
|
2017-10-17 |
2020-08-26 |
Merck Patent GmbH |
Pyrimidine tbk/ikk inhibitor compounds and uses thereof
|
|
SG11202003441VA
(en)
*
|
2017-10-17 |
2020-05-28 |
Merck Patent Gmbh |
PYRIMIDINE ΤΒΚ/ΙΚΚε INHIBITOR COMPOUNDS AND USES THEREOF
|
|
WO2019133810A1
(en)
|
2017-12-28 |
2019-07-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
|
AU2019221019B2
(en)
|
2018-02-13 |
2024-05-02 |
Bayer Aktiengesellschaft |
Use of 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
|
|
EP3788047B1
(en)
|
2018-05-04 |
2024-09-04 |
Incyte Corporation |
Solid forms of an fgfr inhibitor and processes for preparing the same
|
|
BR112020022373A2
(pt)
|
2018-05-04 |
2021-02-02 |
Incyte Corporation |
sais de um inibidor de fgfr
|
|
CA3114198A1
(en)
|
2018-09-25 |
2020-04-02 |
Cardurion Pharmaceuticals, Llc |
Aminopyrimidine compound
|
|
WO2020068846A1
(en)
*
|
2018-09-25 |
2020-04-02 |
Heterocyclic Compound |
Heterocyclic compound
|
|
CA3124324A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Bayer Aktiengesellschaft |
1,3,4-oxadiazoles and their derivatives as new antifungal agents
|
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
EP4027993A4
(en)
*
|
2019-09-13 |
2023-09-20 |
The Broad Institute Inc. |
CYCLO-OXYGENASE 2 INHIBITORS AND THEIR USES
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
KR20220100879A
(ko)
|
2019-10-14 |
2022-07-18 |
인사이트 코포레이션 |
Fgfr 저해제로서의 이환식 헤테로사이클
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021113479A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
KR20220131900A
(ko)
|
2019-12-04 |
2022-09-29 |
인사이트 코포레이션 |
Fgfr 억제제의 유도체
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
JP7587113B2
(ja)
*
|
2020-09-29 |
2024-11-20 |
日亜化学工業株式会社 |
異方性磁性粉末の製造方法および異方性磁性粉末
|
|
WO2022221170A1
(en)
|
2021-04-12 |
2022-10-20 |
Incyte Corporation |
Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
|
|
EP4352060A1
(en)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
TW202313611A
(zh)
|
2021-06-09 |
2023-04-01 |
美商英塞特公司 |
作為ｆｇｆｒ抑制劑之三環雜環
|
|
US12084453B2
(en)
|
2021-12-10 |
2024-09-10 |
Incyte Corporation |
Bicyclic amines as CDK12 inhibitors
|